Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | CAR-T in solid tumors: challenges and future directions

Jon Amund Kyte, MD, PhD, University of Oslo, Oslo, Norway, provides an overview of CAR T-cell therapies in the use of solid tumors and challenges associated with implementation, such as target antigens, tumor heterogeneity and immune suppression. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.